Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The present study intends to investigate the use of fractional doses of sanofi pasteur\'s IMOVAX Polio injected intradermally. The primary objective will be to demonstrate the non-inferiority of fractional doses of IMOVAX Polio administered intradermally versus full doses of IMOVAX Polio administered intramuscularly, in terms of seroprotection rates (polio types 1, 2 and 3) one month after the three-dose primary vaccination administered at 6-10-14 weeks of age.
Epistemonikos ID: 7a0888dc7d15ef2684d20fb3bc6a428836290be0
First added on: May 04, 2024